Natriuretic peptides and myocardial ischaemia

Basic Research in Cardiology

Volumn 99, Issue 2, 2004, Pages 90-93

  Baxter, Gary F ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

ANP; BNP; cGMP; CNP; Guanylyl cyclase; Infarction; Ischaemia; Myocardium; Natriuretic peptide; NPR A; NPR B; Remodelling

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR ALPHA; BRADYKININ; BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE 32; CATECHOLAMINE; CLAMIKALANT; CYCLIC GMP; ENKEPHALINASE INHIBITOR; GLIBENCLAMIDE; HORMONE RECEPTOR; N(G) NITROARGININE METHYL ESTER; NATRIURETIC FACTOR; NESIRITIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM ION; RECOMBINANT HORMONE; UNCLASSIFIED DRUG; URODILATIN;

ARTICLE; AUTOCRINE EFFECT; BIOACCUMULATION; CELL GROWTH; CELL PROLIFERATION; CELL PROTECTION; CHANNEL GATING; CLINICAL STUDY; DRUG SELECTIVITY; EXPERIMENTATION; FIBROBLAST; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE; HORMONE ACTION; HUMAN; INFARCTION; MUSCLE CELL; NONHUMAN; PARACRINE SIGNALING; PATIENT CARE; PLEIOTROPY; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; REPERFUSION; SIGNAL TRANSDUCTION; TIME; TISSUE INJURY; TISSUE REGENERATION; UPREGULATION;

ANIMALS; CELL DIVISION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NATRIURETIC PEPTIDES;

EID: 1542345704     PISSN: 03008428     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00395-004-0458-7     Document Type: Article

References (33)

1. Abell TJ, Richards AM, Ikram H, Espiner EA, Yandle T (1989) Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun 160: 1392-1396
2. Baxter GF (2004) Natriuretic peptides: an introduction. Basic Res Cardiol (in press)
3. Baxter GF, Ebrahim Z (2002) Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol 135: 843-854
4. Cameron VA, Rademaker MT, Ellmers LJ, Espiner EA, Nicholls MG, Richards AM (2000) Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. Endocrinology 141: 4690-4697
5. Cao L, Gardner D (1995) Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25: 227-234
6. D'Souza SP, Yellon DM, Martin C, Schulz R, Heusch G, Onody A, Ferdinandy P, Baxter GF (2003) B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. Am J Physiol Heart Circ Physiol 284: H1592-1600
7. D'Souza SP, Yellon DM, Baxter GF (2003) Cardioprotective action of B-type natriuretic peptide is NO-dependent. Br J Pharmacol 138 (suppl): 21P (abstract)
8. Foy SG, Crozier IG, Richards AM, Nicholls MG, Turner JG, Frampton CM, Ikram H (1995) Neurohormonal changes after acute myocardial infarction. Relationships with haemodynamic indices and effects of ACE inhibition. Eur Heart J 16: 770-778
9. Gross GJ (2000) The role of mitochondrial KATP channels in cardioprotection. Basic Res Cardiol 95 (4): 280-284
10. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K, Yoshimasa T, Hashimoto Y (1995) Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92: 1558-1564
11. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K (2000) Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35: 19-24
12. John SWM, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, Flynn TG, Smithies O (1995) Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679-681 (and erratum Science 267: 1753)
13. Kuhn M (2004) Molecular physiology of natriuretic peptide signalling. Basic Res Cardiol (in press)
14. Kuhn M, Roltwick R, Baba HA, Perriard JC, Schmitz W, Ehler E (2002) Progressive cardiac hypertrophy and dysfunction in atrial natriuretic peptide (GC-A) deficient mice. Heart 87: 368-374
15. Kyriakides ZS, Markianos M, Michalis L, Antoniadis A, Nikolaou NI, Kremastinos DT (2000) Brain natriuretic peptide increases acutely and much more prominently than atrial natriuretic peptide during coronary angioplasty. Clin Cardiol 23: 285-288
16. Lopez MJ, Wong SK, Kishimoto I (1995) Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378: 65-68
17. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, Mukoyama M, Nakao K (1993) Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88: 82-91
18. Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, McCabe CH, Gibson CM, Cannon CP, Braunwald E (2003) Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 41: 1264-1272
19. Mukoyama M, Nakao K, Obata K, Jougasaki M, Yoshimura M, Morita E, Hosoda K, Suga S, Ogawa Y, Yasue H (1991) Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun 180: 431-436
20. Oliver PM, Fox JE, Kim R, Rockman HA, Kim H-S, Reddick RL, Pandey KN, Milgram SL, Smithies O, Maeda N (1997) Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc Natl Acad Sci USA 94: 14730-14735
21. Padilla F, Garcia-Dorado D, Agullo L, Barrabes JA, Inserte J, Escalona N, Meyer M, Mirabet M, Pina P, Soler-Soler J (2001) Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs. Cardiovasc Res 51: 592-600
22. Rastegar MA, Vegh A, Papp JG, Parratt JR (2000) Atrial natriuretic peptide reduces the severe consequences of coronary artery occlusion in anaesthetized dogs. Cardiovasc Drugs Ther 14 (5): 471-479
23. Redondo J, Bishop JE, Wilkins MR (1998) Effect of atrial natriuretic peptide and cyclic GMP phosphodiesterase inhibition on collagen synthesis by adult cardiac fibroblasts. Br J Pharmacol 124: 1455-1462
24. Richards AM, Nicholls MG, Yandle TG, Frampton C, Espiner EA, Turner JG, Buttimore RC, Lainchbury JG, Elliott JM, Ikram H, Crozier IG, Smyth DW (1998) Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97: 1921-1929
25. Richards AM (2004) The natriuretic peptides in heart failure. Basic Res Cardiol (in press)
26. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, McCabe C, Antman EM, Cannon CP, Braunwald E (2002) Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 1760-1763
27. Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G (2001) Signal transduction of ischemic preconditioning. Cardiovasc Res 52: 181-198
28. Takagi G, Kiuchi K, Endo T, Yamamoto T, Sato N, Nejima J, Takano T (2000) Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J Cardiovasc Pharmacol 36: 22-30
29. Talwar S, Squire IB, Downie PF, Davies JE, Ng LL (2000) Plasma N terminal probrain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84:421-424
30. Tamura N, Itoh H, Ogawa Y, Nakagawa O, Harada M, Chun TH, Suga S, Yoshimasa T, Nakao K (1996) cDNA cloning and gene expression of human type Ialpha cGMP-dependent protein kinase. Hypertension 27: 552-557
31. Tateishi J, Masutani M, Ohyanagi M, Iwasaki T (2000) Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 23: 776-780
32. Toth M, Vuorinen KH, Vuolteenaho O, Hassinen IE, Uusimaa PA, Leppaluoto J, Ruskoaho H (1994) Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol 266: H1572-H1580
33. Tsuruda T, Boerrigter G, Huntley BK, Noser JA, Cataliotti A, Costello-Boerrigter LC, Chen HH, Burnett JC Jr (2002) Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 91 1127-1134